APSR logo
Society of 


Table of Contents for
Volume 20 Issue 3
April 2015

Previous issue All issues Next issue Home page View articles online
357Rehabilitation following hospitalization in patients with COPD: Can it reduce readmissions?
Lissa M Spencer
See article, page 395
359Combination pirfenidone and inhaled N-acetylcysteine therapy for IPF: Does it take these two to tango?
Maria I Velez & Anoop M Nambiar
See article, page 445
Challenges in Drug Development for Chronic Lung Diseases
361Delayed access to treatments for rare diseases: Who's to blame?
Karen Feltmate, Peter M Janiszewski, Sheena Gingerich & Michael Cloutier
Lung Cancer Practice, Implementing Evidence From Around the World
370Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)
Nesaretnam Barr Kumarakulasinghe, Nico van Zanwijk & Ross A Soo
Respiratory Disease: Using Lung Function Measurements To Greater Advantage
379Respiratory disease and respiratory physiology: Putting lung function into perspective: Paediatric asthma
Lara S van den Wijngaart, Jolt Roukema & Peter J F M Merkus
See case report in Respirology Case Reports http://dx.doi.org/10.1002/rcr2.92
Watch the Video introducing the Review Series on lung function testing
389Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective
Yuben Moodley, Tamera Corte, Luca Richeldi & Talmadge E King Jr
395Rehabilitation following hospitalization in patients with COPD: Can it reduce readmissions?
Matthew Maddocks, Samantha S C Kon, Sally J Singh & William D-C Man
See Editorial, page 357
405Incidence of viral infection detected by PCR and real-time PCR in childhood community-acquired pneumonia: A meta-analysis
Min Wang, Feng Cai, Xiaodong Wu, Ting Wu, Xin Su & Yi Shi
Editor's choice
Impact of comorbidities on physical activity in COPD
Noriane A Sievi, Oliver Senn, Thomas Brack, Martin H Brutsche, Martin Frey, Sarosh Irani, Jörg D Leuppi, Robert Thurnheer, Daniel Franzen, Malcolm Kohler & Christian F Clarenbach
See Editor's Choice, page 519
419Oxygen desaturation and adverse events during 6-min walk testing in patients with COPD
Mary M Roberts, Jin-Gun Cho, Jacqueline S Sandoz & John R Wheatley
426Tc17 cells are associated with cigarette smoke-induced lung inflammation and emphysema
Hongbin Zhou, Wen Hua, Yan Jin, Chao Zhang, Luanqing Che, Lixia Xia, Jiesen Zhou, Zhihua Chen, Wen Li & Huahao Shen
Interstitial Lung Disease
434Do we need a practice incremental shuttle walk test for patients with interstitial lung disease referred for pulmonary rehabilitation?
Vicki Johnson-Warrington, Louise Sewell, Mike Morgan & Sally Singh
439MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis
Yasushi Horimasu, Shinichiro Ohshimo, Francesco Bonella, Sonosuke Tanaka, Nobuhisa Ishikawa, Noboru Hattori, Nobuoki Kohno, Josune Guzman & Ulrich Costabel
Editor's choice
Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: A case-control study
Susumu Sakamoto, Yoko Muramatsu, Keita Satoh, Fumiaki Ishida, Naoshi Kikuchi, Go Sano, Keishi Sugino, Kazutoshi Isobe, Yujiro Takai & Sakae Homma
See Editorial, page 359
See Editor's Choice, page 519
Interventional Pulmonology
453Differentiating benign from malignant mediastinal lymph nodes visible at EBUS using grey-scale textural analysis
Anthony J Edey, Adrian Pollentine, Claire Doody & Andrew R L Medford
Lung Function
459Effect of equipment dead space on multiple breath washout measures
Anouk Benseler, Sanja Stanojevic, Renee Jensen, Per Gustafsson & Felix Ratjen
Paediatric lung disease
467Respiratory impedance in healthy unsedated South African infants: Effects of maternal smoking
Diane Gray, Dorottya Czövek, Emilee Smith, Lauren Willemse, Ane Alberts, Zoltán Gingl, Graham L Hall, Heather J Zar, Peter D Sly & Zoltán Hantos
Pleural Disease
474Pulmonary manifestations in systemic lupus erythematosus: Association with disease activity
Omer S B Alamoudi & Suzan M Attar
Pulmonary Vascular Disease
481Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension
Saghar Sadeghi, John T Granton, Pooneh Akhavan, Christopher R Pasarikovski, Adrienne M Roos, John Thenganatt, Jakov Moric & Sindhu R Johnson
488Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis
Sung-Soo Jung, Hee-Sun Park, Ju-Ock Kim & Sun-Young Kim
496T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts
Chi Chiu Leung, Wing Cheong Yam, Pak Leung Ho, Wing Wai Yew, Chi Kuen Chan, Wing Sze Law, Shuk Nor Lee, Kwok Chiu Chang, Lai Bun Tai & Cheuk Ming Tam
504Cohort study of a simple 'Step-Up' regimen with the Asthma Control Test
Shaun Holt, Mitesh Patel, Barney Montgomery, Mark Weatherall & Richard Beasley
507Pleural empyema caused by Klebsiella oxytoca: A case series
Elizabeth Suthers, Andrew Rosenstengel, Julie Hart, Joshua R Lewis, Ian Kay, Grant Waterer, Y C Gary Lee & Fraser Brims
510Year in review 2014: Chronic obstructive pulmonary disease, asthma and airway biology
Tow Keang Lim, Fanny W S Ko, Paul S Thomas, Chris Grainge & Ian A Yang
519The Editor recommends this issue's articles
Impact of comorbidities on physical activity in COPD
N A Sievi, O Senn, T Brack, MH Brutsche, M Frey, S Irani, JD Leuppi, R Thurnheer, D Franzen, M Kohler & CF Clarenbach
See page 413

Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: A case-control study
S Sakamoto, Y Muramatsu, K Satoh, F Ishida, N Kikuchi, G Sano, K Sugino, K Isobe, Y Takai & S Homma
See page 445